Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Why Do Active Funds Underperform Benchmark? This overview breaks down fees, manager skill, and market efficiency to explain gaps in performance and how to navigate them.
22,441 articlesAxsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Set up your weekend with a curated mix of Friday reads for investors. This guide rounds up 10 must-check pieces that ...
As AI enthusiasm shakes up the tech market, Microsoft stands out as a potentially steadier megacap. This article brea...
Navitas Semiconductor carved out a standout session as investors reassessed growth catalysts in power semiconductors....
A new barcode and QR code scam is driving losses for utility customers. This guide explains how the fake code payment...
As data centers expand and AI workloads surge, the tech industry faces a critical power reliability challenge. This a...
A looming funding gap could push policymakers toward fixes that feel like benefit cuts to millions. Learn what this p...
L’Oréal rolls out a refreshed sustainability push that links climate goals to profits, highlighting Water Saver tech ...
A high-profile stance can carry a price in Hollywood. This article explains the financial lessons from Susan Sarandon...
When a fintech stock investor trims a large stake in a rising Brazilian payments firm, traders and everyday investors...
Investors are looking at SMH with fresh eyes as AI infrastructure expands. This article explains why a bold predictio...
SpaceX's IPO is on the horizon, but you can gain exposure today through a strategic backdoor. This article explains w...